Chargement en cours...
Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer
S-1 is a novel oral fluorouracil prodrug that plays a role in non-small cell lung cancer (NSCLC). Docetaxel (DTX) is one of the standard agents for relapsed NSCLC. We performed a phase I study of DTX plus S-1 combination therapy as second-line treatment for NSCLC to determine the maximum tolerated d...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3412446/ https://ncbi.nlm.nih.gov/pubmed/22870147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2010.218 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|